Price of Common Stock. The Company has not taken, and will not take, directly or indirectly, any action designed to cause or result in, or that has constituted or that might reasonably be expected to constitute, the stabilization or manipulation of the price of the shares of the Common Stock to facilitate the sale or resale of the Shares.
Price of Common Stock. Neither the Company nor, to its knowledge, any of its affiliates has taken, directly or indirectly, any action designed to or which has constituted or which would reasonably be expected to cause or result, under the Exchange Act or otherwise, in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Shares.
Price of Common Stock. The Company has not taken any action intended to stabilize or manipulate the price of the Company’s shares of the Common Stock to facilitate the sale or resale of the Shares. The Company has not repurchased any of its shares of Common Stock since March 31, 2005.
Price of Common Stock. The Company represents and warrants that it has not taken, directly or indirectly, any action designed to cause or result in, or that has constituted or that might reasonably be expected to constitute the stabilization or manipulation of the price of any securities of the Company to facilitate the transactions contemplated by this Agreement.
Price of Common Stock. The Company has not taken any action intended to stabilize or manipulate the price of the Company Common Stock.
Price of Common Stock. The Company has not and to its knowledge, no one acting on its behalf has, directly or indirectly, (i) taken any action intended to stabilize or manipulate the price of the Company’s shares of the Common Stock to facilitate the sale or resale of the Shares, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of any of the Common Stock or the Shares, other than the Placement Agent’s placement of the Shares, or (iii) paid or agreed to pay any Person any compensation for soliciting another to purchase any other securities of the Company. The Company has not repurchased any of its shares of Common Stock since December 31, 2007.
Price of Common Stock. The Company has not taken, and will not take, directly or indirectly, any action prohibited by Regulation M as promulgated under the Exchange Act that is intended to stabilize or manipulate the price of the shares of the Common Stock to facilitate the sale or resale of the Securities.
Price of Common Stock. The Parent has not taken, and will not take, directly or indirectly, any action designed to cause or result in, or which has constituted or which would reasonably be expected to constitute, the stabilization or manipulation of the price of the Common Stock to facilitate the sale or resale of the Warrants or the Warrant Shares.
Price of Common Stock. 21 5.27 INTERNAL ACCOUNTING CONTROLS....................................21 5.28
Price of Common Stock. On January 31, 2020, the Company announced the approval of Biologics License Application for AR101.
